Who Paid My Doc
Feiba
Biological Hematology
NDC 64193-426-02
General payments
$187,337
Research payments
$469,622
Through program year 2025, $187,337 in general payments and $469,622 in research payments were reported against Feiba (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $56,435 | 12 |
| 2024 | General | $47,501 | 4 |
| 2023 | General | $1,400 | 1 |
| 2022 | General | $8,228 | 3 |
| 2022 | Research | $25,227 | 1 |
| 2021 | General | $70,173 | 43 |
| 2021 | Research | $140,963 | 2 |
| 2020 | General | $3,600 | 1 |
| 2020 | Research | $303,432 | 7 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
64 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.